Publikationen, an denen er mitarbeitet María Eugenia Fernández Santos (22)

2018

  1. Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with st-segment elevation myocardial infarction and left ventricular dysfunction a multicenter randomized, double-blind, and placebo-controlled clinical trial

    Circulation Research, Vol. 123, Núm. 5, pp. 579-589

2016

  1. Cell expansion-dependent inflammatory and metabolic profile of human bone marrow mesenchymal stem cells

    Frontiers in Physiology, Vol. 7, Núm. NOV

  2. Data from acellular human heart matrix

    Data in Brief

2015

  1. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms

    Biochemical Pharmacology, Vol. 93, Núm. 4, pp. 428-439

  2. Acellular human heart matrix: A critical step toward whole heart grafts

    Biomaterials, Vol. 61, pp. 279-289

  3. Comparison of different bone marrow-derived stem cell approaches in reperfused STEMI: A multicenter, prospective, randomized, open-labeled TECAM trial

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2372-2382

  4. Role of atrial tissue remodeling on rotor dynamics: An in vitro study

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 309, Núm. 11, pp. H1964-H1973

2014

  1. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial

    American Heart Journal, Vol. 168, Núm. 1

  2. An in-vitro model of cardiac fibrillation with different degrees of complexity

    IFMBE Proceedings

  3. Inhomogeneous modification of cardiac electrophysiological properties due to Flecainide administration

    IFMBE Proceedings

2013

  1. Resultados clínicos de las técnicas regenerativas en medicina cardiovascular

    Revista Espanola de Cardiologia Suplementos, Vol. 13, Núm. 5, pp. 81-91

2012

  1. Functional multipotency of stem cells: What do we need from them in the heart?

    Stem Cells International

2010

  1. Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study

    American Heart Journal, Vol. 159, Núm. 6, pp. 1154.e1-1154.e8

  2. Editorial: Cultured and freshly isolated adipose tissue-derived cells: Fat years for cardiac stem cell therapy

    European Heart Journal

  3. General Overview of the Sixth International Symposium on Stem Cell Therapy and Cardiovascular Innovations

    Journal of Cardiovascular Translational Research

  4. Stem cell therapy in chronic ischemic heart dysfunction with and without viability

    Cardiovascular and Hematological Disorders - Drug Targets, Vol. 10, Núm. 3, pp. 167-172

2009

  1. Comparison of Neointimal Hyperplasia With Drug-Eluting Stents Versus Bare Metal Stents in Patients Undergoing Intracoronary Bone-Marrow Mononuclear Cell Transplantation Following Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 103, Núm. 12, pp. 1651-1656

  2. Panoramic view of the Fifth International Symposium on Stem Cell Therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain)

    Journal of Cardiovascular Translational Research

2007

  1. Present and future of stem cells for cardiovascular therapy

    Annals of Medicine, Vol. 39, Núm. 6, pp. 412-427

2006

  1. Contemplating the bright future of stem cell therapy for cardiovascular disease

    Nature Clinical Practice Cardiovascular Medicine, Vol. 3, Núm. SUPPL. 1